Yahoo Web Search

Search results

  1. Mark Glickman is an internationally recognized public relations and marketing strategist and consultant with over 25 years of corporate and hospitality experience. Glickman's worked with some...

  2. May 24, 2016 · Marketing and public relations guru Mark Glickman works with some of the world’s leading resort developments, destinations, management companies and other diverse businesses on branding, publicity, special events and driving revenue.

  3. Grab a Copy of My Latest Book. Whether you work in marketing, sales, public relations or operations for a resort, hotel or destination or you’re studying marketing or hospitality management; whether you’re curious about what life is like working in paradise, or you’re just looking for a fun read, you’ll find some eye-opening insights in ...

  4. Strategist and author of Marketing Paradise, Mark Glickman writes about everything from food & beverage and hospitality to marketing and sustainability.

  5. View Mark Glickmans profile on LinkedIn, a professional community of 1 billion members.

  6. synergbiopharma.com › team › mark-glickmanMark Glickman - SYNER-G

    Mark Glickman, with over 20 years in pharma, excels in strategic partnerships and business development, currently serving as Co-CEO at TherapeuticsMD.

  7. May 24, 2016 · Thanks also to Bold Rock Cidery, a beautiful new $5 million, 12,000-square-foot cidery featuring a tasting room with a glass window through which visitors can see Bold Rock’s production process. If you’re ever in the Nelson County, Virginia area, it’s well worth a visit.

  8. Mark Glickman is the current President & CEO of BioFlorida, a statewide organization dedicated to advancing the life sciences industry. In his role, he directs the company's overall strategy to enhance Florida's competitiveness as a top global location for the industry.

  9. This page is about Mark E. Glickman, Ph.D., Senior Lecturer on Statistics at Harvard University.

  10. May 12, 2023 · BOSTON, May 12, 2023 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company on a quest to transform cardiometabolic diseases, today announced the appointment of Mark A. Glickman to its Board of Directors, effective as of May 11, 2023.